| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PGEN | PRECIGEN INC | $4.27 | $4.22 | 1.27% | 32.85x | 17.79x | 9.75x | 18.27x | 0.35x | -$74.32M | -4.85% | $83.79M | 0.23 | $1.61B | 39.50 | ||
| CORT | CORCEPT THERAPEUTICS INC | $67.79 | $39.08 | 73.47% | 44.89x | 31.93x | 7.50x | 8.90x | 0.62x | $194.62M | 2.69% | $833.74M | 7.82 | $7.33B | 66.08 | ||
| TGTX | TG THERAPEUTICS INC | $66.12 | $20.15 | 228.16% | 84.77x | 64.50x | 10.37x | 17.47x | 1.17x | $85.56M | 0.92% | $572.13M | 4.06 | $10.32B | 52.54 | ||
| FENC | FENNEC PHARMACEUTICALS INC | $13.33 | $3.08 | 332.62% | 333.25x | 46.17x | 7.05x | 9.57x | 1.35x | $3.15M | 0.68% | $49.19M | 1.40 | $421.93M | 149.30 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $27.61 | $7.85 | 251.50% | 125.50x | 89.12x | 7.11x | 14.31x | 1.19x | $59.71M | 1.65% | $243.97M | 1.86 | $3.57B | 76.35 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $298.71 | $71.80 | 316.01% | 112.72x | 30.80x | 23.49x | 6.21x | 1.47x | $90.43M | 1.52% | $961.76M | 48.18 | $7.07B | 71.81 | ||
| KRYS | KRYSTAL BIOTECH INC | $315.34 | $75.91 | 315.42% | 41.17x | 40.24x | 19.87x | 6.51x | 2.28x | $310.08M | 3.32% | $1.44B | 48.48 | $8.89B | 33.48 | ||
| RPRX | ROYALTY PHARMA PLC | $68.67 | $34.46 | 99.30% | 44.88x | 12.55x | 11.70x | 4.02x | 0.74x | $2.89B | 9.45% | $9.80B | 21.96 | $47.46B | 45.49 | ||
| HALO | HALOZYME THERAPEUTICS INC | $95.80 | $73.59 | 30.17% | 22.59x | 10.58x | 6.05x | -197.73x | 0.52x | $885.88M | 8.13% | -$55.24M | -0.49 | $13.14B | 16.31 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $95.05 | $14.35 | 562.29% | 66.47x | 72.43x | 7.86x | 10.52x | 3.60x | $197.20M | 2.65% | $710.19M | 9.08 | $7.39B | 48.64 | ||
| VCEL | VERICEL CORP | $58.65 | $8.39 | 599.12% | 88.86x | 77.70x | 9.26x | 7.79x | 3.22x | $57.89M | 1.93% | $384.17M | 7.51 | $2.95B | 54.70 | ||
| ADMA | ADMA BIOLOGICS INC | $13.56 | $6.79 | 99.61% | 17.16x | 16.83x | 5.84x | 6.86x | 1.26x | $132.91M | 4.38% | $438.51M | 1.96 | $3.08B | 12.20 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $247.77 | $128.44 | 92.90% | 68.07x | 16.22x | 3.40x | 3.79x | 0.65x | $1.65B | 10.31% | $4.19B | 64.79 | $19.50B | 17.01 | ||
| TECH | BIO-TECHNE CORP | $72.75 | $15.88 | 358.00% | 66.14x | 35.03x | 9.29x | 5.28x | 1.98x | $308.20M | 2.70% | $2.17B | 13.81 | $11.36B | 34.05 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.28 | $7.80 | 19.05% | 7.31x | 8.12x | 3.73x | 2.31x | 1.40x | $87.07M | 15.80% | $238.92M | 4.02 | $431.28M | 4.49 | ||
| INCY | INCYTE CORP | $117.80 | $52.38 | 124.88% | 56.36x | 34.13x | 3.98x | 4.26x | 0.81x | $684.87M | 2.86% | $5.64B | 27.76 | $20.77B | 23.15 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $536.45 | $143.01 | 275.13% | 34.23x | 28.86x | 10.50x | 6.51x | 2.23x | $3.20B | 2.35% | $20.91B | 82.48 | $137.51B | 27.31 | ||
| EXEL | EXELIXIS INC | $68.29 | $31.03 | 120.05% | 19.79x | 19.50x | 6.75x | 9.09x | 1.33x | $1.16B | 6.89% | $1.83B | 7.43 | $16.52B | 14.78 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $945.53 | $481.25 | 96.48% | 20.11x | 13.46x | 5.69x | 2.92x | 1.05x | $3.83B | 3.98% | $33.50B | 329.39 | $96.86B | 15.51 | ||
| UTHR | UNITED THERAPEUTICS CORP | $577.34 | $207.14 | 178.72% | 20.21x | 21.56x | 7.73x | 3.92x | 2.25x | $867.20M | 3.52% | $6.28B | 146.98 | $23.40B | 14.48 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $33.11 | $27.87 | 18.81% | 10.72x | 8.63x | 1.95x | 1.81x | 0.71x | $322.93M | 16.70% | $1.07B | 18.36 | $1.45B | 5.33 | ||
| VCYT | VERACYTE INC | $25.57 | $9.51 | 168.93% | 16.08x | 13.06x | 3.54x | 1.44x | 3.44x | $161.95M | 7.87% | $1.43B | 17.80 | $1.90B | 13.34 |